News

Zwijnaarde, Belgium – How can Flanders remain a global leader in healthcare innovation while ensuring that promising MedTech companies have access to the capital needed to scale? These questions were at the heart of a visit by Flemish Minister-President and Flemish Minister for innovation Matthias Diependaele to BIO INX, a Ghent-based pioneer in advanced biomaterials for 3D bioprinting.

Zwijnaarde 03/06/2026 - BIO INX, a leading developer of advanced biomaterials for 3D bioprinting, is proud to announce a new partnership with MP Strumenti, who will serve as the official distributor of BIO INX products in Italy. This collaboration marks an important step in BIO INX’s continued European expansion and strengthens its presence in one of Europe’s most dynamic biofabrication markets.

Innovative injectable cell therapy could one day repair worn-out spinal “shock absorbers” — powered by BIO INX’ DEGRAD INX, a cutting-edge biodegradable biomaterial. (Image credit to Rathina Vel Balasubramanian from TU Wien)

We are honored to announce that BIO INX has been recognized as a Top Biomaterials Development Company in Europe – 2026 by Life Sciences Review Europe. This recognition highlights the growing importance of standardized, reproducible biomaterials in advancing the field of biofabrication and regenerative medicine.

Ghent, Belgium, 12/11/2025 - BIO INX, a global leader in advanced bio-inks for 3D bioprinting, proudly announces that Yamato Scientific Co., Ltd. will become its official distributor in Japan. This collaboration marks an important milestone in BIO INX’s global expansion strategy and strengthens its presence in one of the world’s most technologically advanced markets.

Ghent, Belgium / Lausanne, Switzerland – May 19, 2025 – BIO INX and Readily3D proudly announce the launch of READYPCL INX, the world’s first commercially available polyester-based resin for volumetric bioprinting. This innovation marks a significant milestone in the advancement of next-generation bioprinting materials and further cements the collaboration between the two pioneering companies.

A breakthrough in high-resolution 3D bioprinting with the use of DEGRAD INX U100, the world’s first polyester-based biodegradable resin, in a pioneering new two-photon polymerization (2PP) system. This revolutionary technology, developed in the research group led by prof. Aleksandr Ovsianikov at TU Wien, has set a new benchmark as the fastest high resolution 3D printer ever!

A groundbreaking study published in APL Bioengineering demonstrates how advanced 3D bioprinting can revolutionize cancer research by providing realistic in vitro models to study tumor invasion. The research, led by Federico Cantoni and colleagues, of the Maria Tenje Lab at Uppsala University showcases the use of multiphoton lithography to fabricate hydrogel scaffolds that mimic the ECM.

BIO INX Launches BIORES INX: A Gelatin-Based DLP Resin for Bioprinting
BIO INX introduces BIORES INX, a groundbreaking gelatin methacrylamide (GelMA)-based resin for digital light processing (DLP) bioprinting. This resin combines exceptional biocompatibility, ease of use, and cross-platform compatibility, eliminating challenges like heating and water evaporation during printing.

BIO INX and Carl ROTH partner to make advanced bioinks more accessible worldwide. Carl Roth now offers BIO INX’s full portfolio, supporting innovations in tissue engineering and regenerative medicine. This collaboration streamlines logistics and accelerates bioprinting advancements. Explore the range at www.carlroth.com